Skip to main content

Research Repository

Advanced Search

SOLOIST: A Randomized, Double-Blind, Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Effects of SOtagliLiflozin on Clinical Outcomes in HemOdynamIcally STable Patients with Type 2 Diabetes POST worsening Heart Failure. Aug 1, 2018 - Jan 31, 2021
A Randomized, Double-Blind, Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Effects of SOtagliLiflozin on Clinical Outcomes in HemOdynamIcally STable Patients with Type 2 Diabetes POST worsening Heart Failure.